Pandemics

The confirmation of a new COVID variant with immune escape potential in multiple countries, including the US, raises concerns about potential increases in transmission and challenges to existing vaccine efficacy. Concurrently, flu activity remains high with significant pediatric mortality, and avian flu continues to impact both animal and human populations, indicating a persistent risk of zoonotic spillover. Despite advancements in vaccine development and deployment, issues such as low antiviral use among high-risk groups and misinformation about vaccines persist, potentially undermining public health responses. These factors collectively contribute to a sustained moderate risk level, necessitating vigilant monitoring and adaptive public health strategies.